{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T20:30:54Z","timestamp":1723494654695},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.bbr.2012.11.024","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T18:35:00Z","timestamp":1354214100000},"page":"125-132","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Novel treatments in autism spectrum disorders: From synaptic dysfunction to experimental therapeutics"],"prefix":"10.1016","volume":"251","author":[{"given":"Roberto","family":"Canitano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2012.11.024_bib0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/DBP.0b013e3182040acf","article-title":"Management of symptoms in children with autism spectrum disorders: a comprehensive review of pharmacologic and complementary-alternative medicine treatments","volume":"32","author":"Huffman","year":"2011","journal-title":"Journal of Developmental and Behavioral Pediatrics"},{"key":"10.1016\/j.bbr.2012.11.024_bib0010","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00787-009-0076-x","article-title":"Genetics of autistic disorders: review and clinical implications","volume":"19","author":"Duketis","year":"2010","journal-title":"European Child and Adolescent Psychiatry"},{"key":"10.1016\/j.bbr.2012.11.024_bib0015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ajmg.b.31159","article-title":"Autism spectrum disorders and autistic traits: a decade of new twin studies","volume":"156","author":"Ronald","year":"2011","journal-title":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics"},{"key":"10.1016\/j.bbr.2012.11.024_bib0020","doi-asserted-by":"crossref","first-page":"e727","DOI":"10.1542\/peds.2009-1684","article-title":"Clinical genetic testing for patients with autism spectrum disorders","volume":"125","author":"Shen","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbr.2012.11.024_bib0025","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.neuron.2011.05.025","article-title":"Solving the autism puzzle a few pieces at a time","volume":"70","author":"Schaaf","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2012.11.024_bib0030","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/clpt.2011.245","article-title":"Pathways to drug development for autism spectrum disorders","volume":"91","author":"Hampson","year":"2012","journal-title":"Clinical Pharmacology Therapeutics"},{"key":"10.1016\/j.bbr.2012.11.024_bib0035","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/npp.2011.185","article-title":"Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments","volume":"37","author":"Veenstra-VanderWeele","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2012.11.024_bib0040","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1146\/annurev.clinpsy.121208.131151","article-title":"Behavioral treatments in autism spectrum disorder: what do we know","volume":"6","author":"Vismara","year":"2010","journal-title":"Annual Review of Clinical Psychology"},{"key":"10.1016\/j.bbr.2012.11.024_bib0045","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pnpbp.2010.10.015","article-title":"Psychopharmacology of autism: an update","volume":"35","author":"Canitano","year":"2011","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.bbr.2012.11.024_bib0050","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems","volume":"347","author":"McCracken","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.bbr.2012.11.024_bib0055","first-page":"CD009043","article-title":"Aripiprazole for autism spectrum disorders (ASD)","volume":"5","author":"Ching","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.bbr.2012.11.024_bib0060","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1517\/14656566.2011.557661","article-title":"Aripiprazole for the treatment of irritability associated with autism","volume":"12","author":"Farmer","year":"2011","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.bbr.2012.11.024_bib0065","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/archneurol.2010.47","article-title":"Connecting genes to brain in the autism spectrum disorders","volume":"67","author":"Abrahams","year":"2010","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.bbr.2012.11.024_bib0070","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1523\/JNEUROSCI.5685-08.2009","article-title":"Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice","volume":"29","author":"Zhou","year":"2009","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2012.11.024_bib0075","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1073\/pnas.0812394106","article-title":"Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice","volume":"106","author":"Tropea","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.bbr.2012.11.024_bib0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1113\/jphysiol.2009.178905","article-title":"Excitatory amino acid involvement in dendritic spine formation, maintenance and remodelling","volume":"588","author":"McKinney","year":"2010","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.bbr.2012.11.024_bib0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11910-010-0104-8","article-title":"Synapse pathology in psychiatric and neurologic disease","volume":"10","author":"van Spronsen","year":"2010","journal-title":"Current Neurology and Neuroscience Reports"},{"key":"10.1016\/j.bbr.2012.11.024_bib0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nn.2741","article-title":"Dendritic spine pathology in neuropsychiatric disorders","volume":"14","author":"Penzes","year":"2011","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.bbr.2012.11.024_bib0095","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainres.2009.09.120","article-title":"Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders","volume":"1309","author":"Hutsler","year":"2010","journal-title":"Brain Research"},{"key":"10.1016\/j.bbr.2012.11.024_bib0100","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1523\/JNEUROSCI.2623-05.2006","article-title":"Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome","volume":"26","author":"Moretti","year":"2006","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2012.11.024_bib0105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fpsyt.2012.00034","article-title":"Rett syndrome: genes, synapses, circuits, and therapeutics","volume":"3","author":"Banerjee","year":"2012","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.bbr.2012.11.024_bib0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/srep00045","article-title":"The short-time structural plasticity of dendritic spines is altered in a model of Rett syndrome","volume":"1","author":"Landi","year":"2011","journal-title":"Scientific Reports"},{"key":"10.1016\/j.bbr.2012.11.024_bib0115","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00441-006-0274-5","article-title":"The postsynaptic density","volume":"362","author":"Boeckers","year":"2006","journal-title":"Cell and Tissue Research"},{"key":"10.1016\/j.bbr.2012.11.024_bib0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2040-2392-1-15","article-title":"Halpoinsufficiency of the autism-associated SHANK3 gene leads to deficits in synaptic function, social interaction, and social communication","volume":"1","author":"Bozdagi","year":"2010","journal-title":"Molecular Autism"},{"key":"10.1016\/j.bbr.2012.11.024_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-3-14","article-title":"Deletion 22q13.3 syndrome","volume":"3","author":"Phelan","year":"2008","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"10.1016\/j.bbr.2012.11.024_bib0130","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/jmg.2005.038604","article-title":"Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome","volume":"10","author":"Bonaglia","year":"2006","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.bbr.2012.11.024_bib0135","doi-asserted-by":"crossref","first-page":"e1002173","DOI":"10.1371\/journal.pgen.1002173","article-title":"Molecular mechanisms generating and stabilizing terminal 22q13 deletions in 44 subjects with Phelan\/McDermid Syndrome","volume":"7","author":"Bonaglia","year":"2011","journal-title":"PLoS Genetics"},{"key":"10.1016\/j.bbr.2012.11.024_bib0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng1933","article-title":"Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders","volume":"39","author":"Durand","year":"2007","journal-title":"Nature Genetics"},{"key":"10.1016\/j.bbr.2012.11.024_bib0145","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/ajmg.a.33253","article-title":"22q13.3 deletion syndrome: clinical and molecular analysis using array CGH","volume":"152A","author":"Dhar","year":"2010","journal-title":"American Journal of Medical Genetics Part A"},{"key":"10.1016\/j.bbr.2012.11.024_bib0150","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ajmg.b.30822","article-title":"Novel de novo SHANK3 mutation in autistic patients","volume":"150","author":"Gauthier","year":"2009","journal-title":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics"},{"key":"10.1016\/j.bbr.2012.11.024_bib0155","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ajhg.2007.12.009","article-title":"Structural variation of chromosomes in autism spectrum disorder","volume":"82","author":"Marshall","year":"2008","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.bbr.2012.11.024_bib0160","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.brainres.2010.11.005","article-title":"Analysis of a purported SHANK3 mutation in a boy with autism: clinical impact of rare variant research in neurodevelopmental disabilities","volume":"1380","author":"Kolevzon","year":"2011","journal-title":"Brain Research"},{"key":"10.1016\/j.bbr.2012.11.024_bib0165","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/ana.21342","article-title":"Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers","volume":"63","author":"Talos","year":"2008","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.bbr.2012.11.024_bib0170","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/nn1566","article-title":"Regulation of neuronal morphology and function by the tumor suppressors Tsc1andTsc2","volume":"8","author":"Tavazoie","year":"2005","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.bbr.2012.11.024_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conb.2012.04.008","article-title":"Targeted treatment trials for tuberous sclerosis and autism: no longer a dream","volume":"22","author":"Sahin","year":"2012","journal-title":"Current Opinion in Neurobiology"},{"key":"10.1016\/j.bbr.2012.11.024_bib0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature10658","article-title":"Mutations causing syndromic autism define an axis of synaptic pathophysiology","volume":"480","author":"Auerbach","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2012.11.024_bib0185","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2040-2392-1-12","article-title":"Fragile X and autism: Intertwined at the molecular level leading to targeted treatments","volume":"21","author":"Hagerman","year":"2010","journal-title":"Molecular Autism"},{"key":"10.1016\/j.bbr.2012.11.024_bib0190","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.molmed.2010.08.005","article-title":"Potential therapeutic interventions for fragile X syndrome","volume":"16","author":"Levenga","year":"2010","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.bbr.2012.11.024_bib0195","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/ajmg.a.32848","article-title":"Autism spectrum disorder in fragile X syndrome: a longitudinal evaluation","volume":"149A","author":"Hernandez","year":"2009","journal-title":"American Journal of Medical Genetics Part A"},{"key":"10.1016\/j.bbr.2012.11.024_bib0200","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/nn1765","article-title":"Fragile X syndrome and autism at the intersection of genetic and neural networks","volume":"9","author":"Belmonte","year":"2006","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.bbr.2012.11.024_bib0205","doi-asserted-by":"crossref","first-page":"9335","DOI":"10.1073\/pnas.1002762107","article-title":"Region-specific alterations in brain development in one- to three-year-old boys with fragile X syndrome","volume":"107","author":"Hoeft","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.bbr.2012.11.024_bib0210","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-3-642-21649-7_17","article-title":"Fragile X syndrome and targeted treatment trials","volume":"54","author":"Hagerman","year":"2012","journal-title":"Results and Problems in Cell Differentiation"},{"key":"10.1016\/j.bbr.2012.11.024_bib0215","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.coph.2006.08.008","article-title":"Metabotropic glutamate receptors: intracellular signaling pathways","volume":"7","author":"Gerber","year":"2007","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.bbr.2012.11.024_bib0220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuron.2004.09.012","article-title":"LTP and LTD: an embarrassment of riches","volume":"30","author":"Malenka","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2012.11.024_bib0225","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrn2867","article-title":"Long-term depression in the CNS","volume":"11","author":"Collingridge","year":"2010","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.bbr.2012.11.024_bib0230","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1471-4892(01)00119-9","article-title":"Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives","volume":"2","author":"Gasparini","year":"2002","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.bbr.2012.11.024_bib0235","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/jmg.2008.063701","article-title":"A pilot open-label single-dose trial of fenobam in adults with fragile X syndrome","volume":"46","author":"Berry-Kravis","year":"2009","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.bbr.2012.11.024_bib0240","first-page":"3","article-title":"Anxiolytics: past, present, and future agents","volume":"64","author":"Nemeroff","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.bbr.2012.11.024_bib0245","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuropharm.2006.04.018","article-title":"L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors","volume":"51","author":"Atack","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2012.11.024_bib0250","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/cap.2006.16.525","article-title":"Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial","volume":"16","author":"Berry-Kravis","year":"2006","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/j.bbr.2012.11.024_bib0255","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/0883073807302611","article-title":"Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability","volume":"22","author":"Chez","year":"2007","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.bbr.2012.11.024_bib0260","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/DBP.0b013e31817dc447","article-title":"Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome","volume":"29","author":"Berry-Kravis","year":"2008","journal-title":"Journal of Developmental and Behavioral Pediatrics"},{"key":"10.1016\/j.bbr.2012.11.024_bib0265","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1352\/1944-7558-115.5.433","article-title":"Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures","volume":"115","author":"Utari","year":"2010","journal-title":"American Journal on Intellectual and Developmental Disabilities"},{"key":"10.1016\/j.bbr.2012.11.024_bib0270","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.bbr.2012.11.024_bib0275","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1177\/08830738040190090401","article-title":"Brain abnormalities in tuberous sclerosis complex","volume":"19","author":"DiMario","year":"2004","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.bbr.2012.11.024_bib0280","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(97)80012-8","article-title":"Association of tuberous sclerosis of temporal lobes with autism and atypical autism","volume":"349","author":"Bolton","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2012.11.024_bib0285","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/brain\/awf124","article-title":"Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex","volume":"125","author":"Bolton","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2012.11.024_bib0290","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1023\/A:1005679108529","article-title":"Autism and the cerebellum: evidence from tuberous sclerosis","volume":"30","author":"Weber","year":"2000","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/j.bbr.2012.11.024_bib0295","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1212\/WNL.57.7.1269","article-title":"Autism in tuberous sclerosis complex is related to both cortical and subcortical dysfunction","volume":"57","author":"Asano","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2012.11.024_bib0300","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1177\/08830738060210100301","article-title":"Cerebellar lesions in tuberous sclerosis complex: neurobehavioral and neuroimaging correlates","volume":"21","author":"Eluvathingal","year":"2006","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.bbr.2012.11.024_bib0305","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1083\/jcb.jcb.200206108","article-title":"Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent","volume":"159","author":"Jaeschke","year":"2002","journal-title":"Journal of Cell Biology"},{"key":"10.1016\/j.bbr.2012.11.024_bib0310","doi-asserted-by":"crossref","first-page":"35364","DOI":"10.1074\/jbc.M205838200","article-title":"Phosphatidylinositol 3- kinase\/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin","volume":"277","author":"Dan","year":"2002","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.bbr.2012.11.024_bib0315","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling","volume":"4","author":"Inoki","year":"2002","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.bbr.2012.11.024_bib0320","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression on astrocytomas in tuberous sclerosis comlex","volume":"59","author":"Franz","year":"2008","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.bbr.2012.11.024_bib0325","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"3","author":"Krueger","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.bbr.2012.11.024_bib0330","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejpn.2011.03.010","article-title":"Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex","volume":"15","author":"Jozwiak","year":"2011","journal-title":"European Journal of Paediatric Neurology"},{"key":"10.1016\/j.bbr.2012.11.024_bib0335","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.eplepsyres.2010.01.008","article-title":"Diffusion tensor imaging identifies changes in normal-appearing white matter within the epileptogenic zone in tuberous sclerosis complex","volume":"89","author":"Widjaja","year":"2010","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.bbr.2012.11.024_bib0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2012.05.004","article-title":"PTEN signaling in autism spectrum disorders","author":"Zhou","year":"2012","journal-title":"Current Opinion in Neurobiology"},{"key":"10.1016\/j.bbr.2012.11.024_bib0345","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0079-6123(08)00435-4","article-title":"Oxytocin and experimental therapeutics in autism spectrum disorders","volume":"170","author":"Bartz","year":"2008","journal-title":"Progress in Brain Research"},{"key":"10.1016\/j.bbr.2012.11.024_bib0350","first-page":"127","article-title":"Oxytocin: the great facilitator of life","volume":"88","author":"Lee","year":"2009","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.bbr.2012.11.024_bib0355","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000321035","article-title":"The contribution of oxytocin and vasopressin to mammalian social behavior: potential role in autism spectrum disorder","volume":"18","author":"Harony","year":"2010","journal-title":"Neuro-signals"},{"key":"10.1016\/j.bbr.2012.11.024_bib0360","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.neuron.2010.03.005","article-title":"The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior","volume":"65","author":"Insel","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2012.11.024_bib0365","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.biopsych.2010.12.022","article-title":"Rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism","volume":"69","author":"Sala","year":"2011","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.bbr.2012.11.024_bib0370","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.biopsych.2011.03.020","article-title":"A complicated picture of oxytocin action in the central nervous system revealed","volume":"69","author":"Ring","year":"2011","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.bbr.2012.11.024_bib0375","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1248\/bpb.34.1369","article-title":"CD38 gene knockout juvenile mice: a model of oxytocin signal defects in autism","volume":"34","author":"Higashida","year":"2011","journal-title":"Biological and Pharmaceutical Bulletin"},{"key":"10.1016\/j.bbr.2012.11.024_bib0380","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature05526","article-title":"CD38 is critical for social behaviour by regulating oxytocin secretion","volume":"446","author":"Jin","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2012.11.024_bib0385","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.febslet.2011.05.004","article-title":"Are retinoids potential therapeutic agents in disorders of social cognition including autism","volume":"585","author":"Ebstein","year":"2011","journal-title":"FEBS Letters"},{"key":"10.1016\/j.bbr.2012.11.024_bib0390","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0006-3223(97)00439-3","article-title":"Plasma oxytocin levels in autistic children","volume":"43","author":"Modahl","year":"1998","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.bbr.2012.11.024_bib0395","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0006-3223(01)01139-8","article-title":"Oxytocin and autistic disorder: alterations in peptide forms","volume":"50","author":"Green","year":"2001","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.bbr.2012.11.024_bib0400","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jaac.2012.04.010","article-title":"Examining autism spectrum disorders by biomarkers: example from the oxytocin and serotonin systems","volume":"51","author":"Hammock","year":"2012","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"August (3)","key":"10.1016\/j.bbr.2012.11.024_bib0405","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.biopsych.2011.12.025","article-title":"Sensitive parenting is associated with plasma oxytocin and polymorphisms in the OXTR and CD38 genes","volume":"72","author":"Feldman","year":"2012","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.bbr.2012.11.024_bib0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2012.06.011","article-title":"Oxytocin administration to parent enhances infant physiological and behavioural readiness for social engagement","author":"Weisman","year":"2012","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.bbr.2012.11.024_bib0415","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.npp.1300021","article-title":"Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders","volume":"1","author":"Hollander","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2012.11.024_bib0420","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.biopsych.2006.05.030","article-title":"Oxytocin increases retention of social cognition in autism","volume":"4","author":"Hollander","year":"2007","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.bbr.2012.11.024_bib0425","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.biopsych.2009.09.020","article-title":"Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders","volume":"67","author":"Guastella","year":"2010","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.bbr.2012.11.024_bib0430","article-title":"Oxytocin enhances paternal sensitivity to a child with autism: a double-blind within-subject experiment with intranasally administered oxytocin","author":"Naber","year":"2012","journal-title":"Journal of Autism and Developmental Diosrders"},{"key":"10.1016\/j.bbr.2012.11.024_bib0435","first-page":"301","article-title":"Social effects of oxytocin in humans: context and person matter","volume":"7","author":"Bartz","year":"2011","journal-title":"Trends in Cognitive Sciences"},{"key":"10.1016\/j.bbr.2012.11.024_bib0440","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.nurt.2010.05.006","article-title":"Autism and oxytocin: new developments in translational approaches to therapeutics","volume":"3","author":"Green","year":"2010","journal-title":"Neurotherapeutics"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432812007462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432812007462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T03:45:10Z","timestamp":1562384710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432812007462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":88,"alternative-id":["S0166432812007462"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2012.11.024","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}